AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Microdosing Terzepatide: A Closer Look
This chapter explores the microdosing of terzepatide, focusing on its unconventional 0.5 milligram dosage and the implications for inflammation rather than weight loss. It discusses early trial results, comparisons with dulaglutide, and the importance of biomarkers in evaluating drug effectiveness for managing blood glucose and insulin secretion.